The Effect of Seoritae Extract in Men with Mild to Moderate Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia

Table 2

Demographic characteristics and outcome measures at baseline.

	SE group; ()	Placebo group; ()	Between groups; value
Age	64.1 ± 6.3	65.1 ± 7.9	0.647
Weight (kg)	69.1 ± 7.7	71.9 ± 9.6	0.158
Height (cm)	168.7 ± 5.8	169.0 ± 5.6	0.848
Comorbidity	21 (53.8)	27 (72.9)	0.084
Prostate volume (cc)	42.7 ± 13.5	34.0 ± 14.2	0.003
IPSS	12.9 ± 3.6	13.0 ± 3.7	0.925
Voiding score	8.1 ± 3.0	7.9 ± 2.9	0.875
Storage score	4.9 ± 1.9	5.1 ± 2.1	0.953
IPSS QoL	3.3 ± 0.8	3.4 ± 0.8	0.309
	13.3 ± 5.9	14.5 ± 4.8	0.410
PVR	32.2 ± 29.3	45.7 ± 49.7	0.484
PSA	1.7 ± 1.4	1.4 ± 1.3	0.065

Mean ± SD or (%).